CD19 and CD20 B-Cell Depletion in MG

05 Nov 2026 0 comments

CD19 and CD20 targeting reach different points along the B-cell lineage, creating distinct clinical questions about efficacy, onset, and patient selection in MG. Supported by Vor Bio Medical Affairs.

Source: NeurologyLive Published 05 Nov 2026 Imported 05 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment